Major cardiovascular events and associated factors among routine hemodialysis patients with end-stage renal disease at tertiary care hospital in Somalia
暂无分享,去创建一个
[1] B. Derseh,et al. Mortality and predictors of Chronic Kidney Diseases (CKD) in selected dialysis centers in Addis Ababa, Ethiopia , 2022, medRxiv.
[2] A. Jardine,et al. A Randomized, Controlled Trial of the Effect of Allopurinol on Left Ventricular Mass Index in Hemodialysis Patients , 2020, Kidney international reports.
[3] M. Petersen,et al. The epidemiology of chronic kidney disease (CKD) in rural East Africa: A population-based study , 2020, PloS one.
[4] Y. Khader,et al. Risk Factors for End-Stage Renal Failure Among Patients on Hemodialysis in Aljomhory Hospital, Sa’adah Governorate, Yemen: Hospital-Based Case-Control Study , 2019, JMIR public health and surveillance.
[5] I. Ssinabulya,et al. Utility of albumin to creatinine ratio in screening for microalbuminuria among newly diagnosed diabetic patients in Uganda: a cross sectional study , 2019, African health sciences.
[6] S. Abdulla,et al. The epidemiology of chronic kidney disease and the association with non-communicable and communicable disorders in a population of sub-Saharan Africa , 2018, PloS one.
[7] M. Daha,et al. Intradialytic Complement Activation Precedes the Development of Cardiovascular Events in Hemodialysis Patients , 2018, Front. Immunol..
[8] Shigeru Tanaka,et al. Cardiothoracic Ratio and All-Cause Mortality and Cardiovascular Disease Events in Hemodialysis Patients: The Q-Cohort Study. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[9] Shuzo Kobayashi. Cardiovascular Events in Hemodialysis Patients: Challenging against Vascular Calcification , 2017, Annals of vascular diseases.
[10] N. Lloberas,et al. Association of ANRIL gene polymorphisms with major adverse cardiovascular events in hemodialysis patients. , 2017, Clinica chimica acta; international journal of clinical chemistry.
[11] P. Kerr,et al. Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices , 2016, The Lancet.
[12] A. Subbiah,et al. Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup , 2016, Heart Asia.
[13] C. Lim,et al. Predictor of cardiovascular risks in end stage renal failure patients on maintenance dialysis , 2015, Pakistan journal of medical sciences.
[14] A. Kengne,et al. Acute hemodialysis complications in end‐stage renal disease patients: The burden and implications for the under‐resourced Sub‐Saharan African health systems , 2012, Hemodialysis international. International Symposium on Home Hemodialysis.
[15] Pedagógia,et al. Cross Sectional Study , 2019 .
[16] A. Kengne,et al. Referral of Patients with Kidney Impairment for Specialist Care in a Developing Country of Sub-Saharan Africa , 2009, Renal failure.
[17] R. Foley,et al. Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. , 2005, Journal of the American Society of Nephrology : JASN.
[18] Tom Chan,et al. Identifying patients with chronic kidney disease from general practice computer records. , 2005, Family practice.
[19] M. Rocco,et al. Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. , 2004, Kidney international.
[20] A. Jardine,et al. Cardiovascular complications of renal disease , 2001, Heart.
[21] R. Foley,et al. Clinical epidemiology of cardiovascular disease in chronic renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[22] S. Leeder,et al. A population based study , 1993, The Medical journal of Australia.
[23] N. Vaziri,et al. Cardiac Pathology in Patients with End-Stage Renal Disease Maintained on Hemodialysis , 1993, The International journal of artificial organs.
[24] S. Rostand,et al. Dialysis-associated ischemic heart disease: insights from coronary angiography. , 1984, Kidney international.
[25] B. Scribner,et al. Accelerated atherosclerosis in prolonged maintenance hemodialysis. , 1974, The New England journal of medicine.
[26] N. Powe,et al. Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients. , 2017, Journal of the American Society of Nephrology : JASN.
[27] Xinling Liang,et al. Pulmonary hypertension as an independent predictor of cardiovascular mortality and events in hemodialysis patients , 2013, International Urology and Nephrology.
[28] P. Aljama,et al. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)]. , 2005, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.